Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
A dual diffusion model enables 3D molecule generation and lead optimization based on target pockets
2024 Standout
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
2023 Standout
Works of Olaf Prien being referenced
Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial
2019
From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2‐Inhibitors
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Olaf Prien | 136 | 124 | 68 | 96 | 16 | 343 | |
| Weifang Shan | 95 | 151 | 23 | 101 | 13 | 332 | |
| Shevan Silva | 154 | 69 | 24 | 144 | 17 | 350 | |
| Donna Wei | 49 | 146 | 63 | 140 | 14 | 374 | |
| Andrew K. Kwegyir‐Afful | 182 | 36 | 20 | 241 | 12 | 381 | |
| Martina Fitzek | 25 | 91 | 26 | 212 | 21 | 365 | |
| Takashi Shirakawa | 34 | 42 | 64 | 150 | 22 | 386 | |
| Bertrand Heckmann | 57 | 86 | 16 | 229 | 16 | 392 | |
| Olli Törmäkangas | 245 | 53 | 71 | 103 | 8 | 342 | |
| L. R. HUGHES | 81 | 79 | 10 | 198 | 14 | 394 | |
| Jingle Xi | 31 | 78 | 18 | 144 | 10 | 327 |
All Works
Loading papers...